The briefings
The serialised archive. Every issue carries the same seven numbered sections in the same order, so the format never has to be relearned.
Issue 001: the licensing power that exists and has not been switched on
A statutory power to license non surgical cosmetic procedures in England has sat on the books unexercised. The sector has spent that period behaving as though the scheme already governs it.
Issue 002: prescribing at a distance, and the fault line under the sector
Botulinum toxin is a prescription only medicine. Who assesses the patient, and whether they were ever in the room, is the structural weak point in UK aesthetics.
Issue 003: the advertising rulebook nobody reads until they are in it
Prescription only medicines may not be advertised to the public. Most of the sector's marketing is written as though that rule were a formality.
Issue 004: the under 18 line, and what it revealed about the rest
England legislated specifically to stop cosmetic injectables being administered to children. The interesting part is what the existence of that Act implies about adults.
Issue 005: devices are not medicines, and the filler gap that follows
Most dermal fillers are regulated as medical devices. That is a conformity route, not a clinical endorsement, and the sector's marketing treats the two as interchangeable.
Issue 006: the symptom search, and how patients now arrive
Patients describe a problem in their own words and expect a system to translate it. The sector's content is still organised around what it sells.
Issue 007: indemnity, and the quiet gatekeeper of the sector
The insurance market decides more about who practises in UK aesthetics than any regulator currently does, and it does so without a consultation.
Issue 008: consolidation and the key person problem
Aesthetics businesses are bought for their multiples and sold back for their dependence on one person. The cycle is structural, not a failure of individual deals.
Issue 009: training, qualifications and the level seven argument
The sector argues about qualification levels as though the level were the point. The level is a proxy for something nobody has agreed how to measure.
Issue 010: complications, and the data that does not exist
Nobody counts complications in UK aesthetics in any systematic way. Every complication rate you have been quoted rests on that absence.
Issue 011: four nations, four answers
Health is devolved. Almost every confident statement about UK aesthetics regulation is wrong in at least one of the four nations, usually more.
Issue 012: price, finance and the deposit
Offering to spread the cost of a cosmetic procedure is a regulated activity. A surprising number of clinics do it without noticing that.
Issue 013: regenerative claims and the distance to the evidence
The word regenerative is doing an enormous amount of commercial work in this sector, and the evidence base underneath it is not the same shape as the marketing.
Issue 014: records, data and what a clinic is actually holding
An aesthetics clinic holds health data, images of identifiable people and consent records. Most treat that estate as a marketing asset.
Issue 015: the workforce question, and who is actually doing this work
Four professional regulators, several thousand practitioners outside all of them, and no census. The workforce is the sector's largest unknown.
Issue 016: where authority comes from now, citation, entity and the answer engine
Ranking was a position. Citation is a decision about who to trust. The sector has spent twenty years optimising for the first.
The briefing rail
Seven sections, numbered, in this order, in every issue. The format does not vary. How the format works.
Regulation
What changed, or did not, in the rules that bind the sector.
Discovery
What changed in search, in answer engines, and in how patients find anyone.
The bodies
What the trade bodies, registers and regulators actually said.
The consultation room
What patients are asking that they were not asking before.
Claims watch
Claims being made that will not survive scrutiny.
Unit economics
The structural money mechanics under the week's noise.
Direction of travel
Where the sector is actually heading, labelled as the analysis it is.
Every issue, without exception
The same seven, in this order. Each closes with a what this means analyst note, and every forward looking line carries a confidence marker.
This article contains no commercial links of any kind. No affiliate links, no sponsored placements, and no links to any clinic, practitioner, agency, brand, product or retailer. Nobody paid for it, nobody previewed it and nobody outside the editorial team saw it before publication.
This publication does not name, rank or rate clinics, practitioners or agencies, because it has assessed none of them. Our funding is set out in full on the about page, the sponsor position is on the sponsorship page, and our commitments are in our editorial standards.
This is trade analysis, not medical or legal advice.
The briefing, when the next issue is published
The current issue is free. One email when a new numbered issue is published, and a note when a standing reference is revised, with the date and what changed. No treatment offers, no clinic recommendations and no rankings, because we publish none of those.